Thomas W. Sweet - 16 Dec 2025 Form 4 Insider Report for Medline Inc. (MDLN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 Jun 2026, 17:55:59 UTC
Prior SEC filing
20 Jun 2025
Next SEC filing
17 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Nicole Fritz, Attorney-in-Fact

Key filing fact

Thomas W. Sweet filed Form 4 for Medline Inc. (MDLN) on 15 Jun 2026.

Key facts

  • This page summarizes Thomas W. Sweet's Form 4 filing for Medline Inc. (MDLN).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 15 Jun 2026, 17:55.

Change

  • Previous filing in this sequence was filed on 20 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001399072 Primary reporting owner

Sweet Thomas W

Relationship
Director
Address
C/O MEDLINE INC., 3 LAKES DRIVE, NORTHFIELD
Signature
/s/ Nicole Fritz, Attorney-in-Fact
Signature date
15 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDLN transaction

Class A Common Stock

Award

Transaction value
Shares
+12,413
Change %
Price
Shares after
12,413
Date
16 Dec 2025
Ownership
By Mallard Advisory LLC
Footnotes
F1, F2
MDLN transaction

Class A Common Stock

Award

Transaction value
Shares
+5,387
Change %
Price
$0.000000*
Shares after
5,387
Date
11 Jun 2026
Ownership
Direct
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These securities were acquired in connection with the reclassification of the interests of Medline Holdings, LP prior to the Issuer's initial public offering (as more fully described in the Registration Statement on Form S-1). These securities were previously reported on the Reporting Person's Form 3 filed on December 17, 2025. Represents a grant of restricted stock units ("RSUs") that vest on March 30, 2027.

Footnote F2

These securities are held by Mallard Advisory LLC, of which the Reporting Person is a manager.

Footnote F3

Represents a grant of RSUs that vest on the earlier of (i) the first anniversary of the date of grant, and (ii) the next annual meeting of stockholders following the date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .